Seeking Alpha

Michael Becker » Articles » Most Commented |

Sort by:
Latest | Editors' Picks (6) | Most Commented | Most Popular
  • Much Ado About Medarex
    on Jun 25, 2009 • MEDX • 11 Comments
  • Bayer's Bold New Bet Fails to Rain on Spectrum Pharma
    on Sep 04, 2009 • SPPI, BIIB, GSK • 10 Comments
  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
    on Jun 19, 2009 • MIPI, DNDN, OGXI • 6 Comments
  • Iron Safety Hits AMAG Pharmaceuticals
    on Feb 04, 2010 • AMAG, WPI • 5 Comments
  • Developments for Parkinson's Disease Ignite Investor Enthusiasm
    on Nov 16, 2009 • IPXL, SRDX, BPAX • 5 Comments
  • Keryx: Another Beneficiary of the ASCO Effect
    on Jun 03, 2009 • KERX, AEZS, EXEL • 5 Comments
  • Healthcare Reform vs Innovation and Growth?
    on Oct 13, 2009 • 4 Comments
  • Three Recent Biotech Activist Wins by Carl Icahn
    on Aug 31, 2009 • ALKS, AMLN, AZN • 4 Comments
  • Genzyme's Manufacturing Disruption Highlights Investment Opportunities
    on Jul 20, 2009 • GENZ, FOLD, CYTR • 4 Comments
  • Chink in the Biotechnology Armor
    on Mar 01, 2009 • LJPC, HEB, SPPI • 4 Comments
  • Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
    on Jul 01, 2009 • SPPI, GSK • 3 Comments
  • For Biotech in 2010, It's Déjà Vu All Over Again
    on Mar 08, 2010 • MNKD, ITMN, AMLN • 2 Comments
  • 11 Ache-Free Investment Opportunities in Neuropathic Pain
    on Sep 30, 2009 • ACAD, ADLR, AGN • 2 Comments
  • Biotech Stocks and the ASCO-Effect
    on Jun 01, 2009 • PPHM, PARD, DNDN • 2 Comments
  • Where Might Genentech Investors Redeploy $47B?
    on Mar 16, 2009 • DNA, BIIB, LJPC • 2 Comments
  • Biotech’s 2009 Stealth Small Cap Rally
    on Jan 04, 2010 • AMGN, AMLN, BIIB • 1 Comment
  • Buyout Buzz at ASH Hematology Confab
    on Dec 07, 2009 • CELG, ZIOP, ALTH • 1 Comment
  • Cash for Cardiovascular: Who Might Be Next?
    on Aug 12, 2009 • AMGN, ASTM, BHRT • 1 Comment
  • Treating Parkinson’s Disease - Investment Opportunities and Challenges
    on Aug 03, 2009 • AMGN, AVGN, DEPO • 1 Comment
  • ADA Meeting 2009: Novel Diabetes Therapies Presented
    on Jun 24, 2009 • LLY, SNY, NVO • 1 Comment
  • Bullish Thesis for Biotech Remains Intact
    on Feb 05, 2009 • FRX, CYPB, GERN • 1 Comment
  • 2009: Positive Outlook for Biotech
    on Jan 08, 2009 • AMGN, ARQL, CBST • 1 Comment
  • BMT Tandem Meetings Review: Gut Check Time for Graft-Versus-Host Disease Companies
    on Mar 01, 2010 • OSIR, CELG • Comment!
  • Biotech Deal Activity Slows - The Pause that Refreshes?
    on Jan 17, 2010 • CEPH, AMGN, MDT • Comment!
  • Graft-Versus-Host Disease: Failures and Future Opportunities
    on Dec 10, 2009 • OSIR, CYCC, XOMA • Comment!
  • 13 Biotechs to Watch for at Hematology Conference
    on Nov 30, 2009 • AEZS, ALTH, ARIA • Comment!
Articles by Ticker

Latest Comments on Michael Becker's Articles

  1. mgw6 on For Biotech in 2010, It's Déjà Vu All Over Again: The key to success for biotech companies remains the same...... more »
  2. true_bandyt on For Biotech in 2010, It's Déjà Vu All Over Again: i've got shares in PTN...hoping for a good year more »
  3. Michael Becker on Iron Safety Hits AMAG Pharmaceuticals: You are correct, 1,000 to 2,000 serious ADEs (versus the incorrect... more »
  4. hoopdreamerz@yahoo.com on Iron Safety Hits AMAG Pharmaceuticals: Michael, thanks for the response. I assume you mean 1,000-2,000... more »
  5. Michael Becker on Iron Safety Hits AMAG Pharmaceuticals: Hoopdreamerz - According to the company's press release from... more »
  6. hoopdreamerz@yahoo.com on Iron Safety Hits AMAG Pharmaceuticals: Any follow up given todays AMAG disclosure? 40 SAE's out of 3500... more »
  7. pod on Iron Safety Hits AMAG Pharmaceuticals: This the single most accurate and educational post about a... more »
  8. aadhar on 11 Ache-Free Investment Opportunities in Neuropathic Pain: to treat these patients has been difficult. This has created an... more »
  9. halochief007 on Biotech’s 2009 Stealth Small Cap Rally: Thank you for mentioning Soligenix (sngx). They have started a... more »
  10. Wall Street Teacher on Buyout Buzz at ASH Hematology Confab: Long and still hopeful on ZIOP. The dilution was painful but... more »
  11. jameskildare on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Chronic pain is very severe and this affects people's life, long... more »
  12. jimmy Turano on Three Recent Biotech Activist Wins by Carl Icahn: HAPPY THANKSGIVING MIKE BECKER. I THOUGHT SOMEHOW, I COULD REACH... more »
  13. Michael Becker on Developments for Parkinson's Disease Ignite Investor Enthusiasm: A comprehensive review of the Parkinson's disease therapeutic... more »
  14. Michael Becker on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Thank you. Unfortunately, we did not perform the currency... more »
  15. Vitautas on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Mr. Becker! Why you don't mentioned Newron Pharma when you talk... more »